{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:28:45Z","timestamp":1791962925446,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1016\/s0002-9394(02)01759-2","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T07:34:16Z","timestamp":1041060856000},"page":"26-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis"],"prefix":"10.1016","volume":"135","author":[{"given":"Douglas A","family":"Jabs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H","family":"Kempen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9394(02)01759-2_BIB1","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB2","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB3","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","article-title":"Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine","volume":"166","author":"Gallant","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9394(14)70789-5","article-title":"AIDS and ophthalmology","volume":"124","author":"Jabs","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB7","first-page":"1931","article-title":"Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997","volume":"12","author":"Holtzer","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1086\/313612","article-title":"Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy","volume":"30","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archopht.1989.01070010077031","article-title":"Cytomegalovirus retinitis and acquired immunodeficiency syndrome","volume":"107","author":"Jabs","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/514249","article-title":"Cytomegalovirus resistance and viral resistance","volume":"177","author":"Jabs","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB11","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.42.9.2240","article-title":"Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis","volume":"42","author":"Jabs","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0002-9394(14)70217-X","article-title":"Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir","volume":"119","author":"Dunn","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0002-9394(01)01161-8","article-title":"Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immune deficiency syndrome and cytomegalovirus retinitis","volume":"132","author":"Jabs","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB14","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0161-6420(94)31181-X","article-title":"Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes","volume":"101","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/infdis\/168.6.1506","article-title":"Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis","volume":"168","author":"Kuppermann","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/infdis\/172.4.951","article-title":"Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis","volume":"172","author":"Arevalo","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/09286589709058060","article-title":"Viral resistance and CMV retinitis","volume":"4","author":"Enger","year":"1997","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9394(98)00134-2","article-title":"Cytomegalovirus retinitis and viral resistance","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0166-0934(90)90122-V","article-title":"Rapid antiviral DNA-DNA hybridization assay for human cytomegalovirus","volume":"28","author":"Dankner","year":"1990","journal-title":"J Virol Method"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archopht.1996.01100140023002","article-title":"Cytomegalovirus retinitis and viral resistance","volume":"114","author":"Jabs","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/infdis\/163.4.716","article-title":"Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection","volume":"163","author":"Drew","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB22","first-page":"179","article-title":"Antiviral susceptibility of cytomegalovirus","volume":"1","author":"Drew","year":"1993","journal-title":"Clin Diagn Virol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/317931","article-title":"Mutations conferring ganciclovir resistance in a cohort of patients with AIDS and cytomegalovirus retinitis","volume":"183","author":"Jabs","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archopht.1996.01100130021004","article-title":"Combination foscarnet and ganciclovir therapy versus monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/514039","article-title":"Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir","volume":"176","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9394(98)00285-2","article-title":"Discontinuing anti-CMV therapy in patients with immune reconstitution after combination antiretroviral therapy","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB27","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.282.17.1633","article-title":"Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis","volume":"282","author":"Whitcup","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002030-200001280-00013","article-title":"CMV retinitis recurs after stopping treatment in virological and immunologic failures of potent antiretroviral therapy","volume":"14","author":"Torriani","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199707103370203","article-title":"Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant","volume":"337","author":"Musch","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB30","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB32","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model counting process","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Statistics"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/339603","article-title":"Comparison of cytomegalovirus UL97 gene sequences in the blood and vitreous of patients with AIDS and cytomegalovirus retinitis","volume":"185","author":"Hu","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archopht.119.4.554","article-title":"Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients","volume":"119","author":"Holbrook","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB35","first-page":"33","article-title":"Retinal detachment risk in cytomegalovirus retinitis related to the acquired immune deficiency syndrome","volume":"119","author":"Kempen","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9394(01)00840-6","article-title":"The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome","volume":"131","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01759-2_BIB37","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/JCM.37.5.1431-1435.1999","article-title":"Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis","volume":"37","author":"Jabs","year":"1999","journal-title":"J Clin Microbiol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402017592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402017592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:30:07Z","timestamp":1757593807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939402017592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0002939402017592"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9394(02)01759-2","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9394(02)01759-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Science Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}